AKTX
Akari Therapeutics PLC
NASDAQ: AKTX · HEALTHCARE · BIOTECHNOLOGY
$5.35
+2.10% today
Updated 2026-04-30
Market cap
$6.00M
P/E ratio
0.00
P/S ratio
478,368.50x
EPS (TTM)
$0.00
Dividend yield
—
52W range
$3 – $59
Volume
0.3M
Akari Therapeutics PLC (AKTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-68.40%
ROA
-15.40%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2010 | — | $-675000.00 | — | — | — |
| 2011 | — | $-2.12M | — | — | — |
| 2012 | — | $-1.44M | — | — | — |
| 2013 | $0.00 | $-3.62M | — | — | — |
| 2014 | $0.00 | $-9.65M | — | — | — |
| 2015 | $0.00 | $-45.32M | — | — | — |
| 2016 | $0.00 | $-18.14M | — | — | — |
| 2017 | $0.00 | $-27.92M | — | — | — |
| 2018 | $0.00 | $-19.95M | — | — | — |
| 2019 | $0.00 | $-16.85M | — | — | — |
| 2020 | $0.00 | $-17.08M | — | — | — |
| 2021 | $0.00 | $-17.42M | — | — | — |
| 2022 | $0.00 | $-17.75M | — | — | — |
| 2023 | $0.00 | $-10.01M | — | — | — |
| 2024 | $0.00 | $-19.79M | — | — | — |
| 2025 | $0.00 | $-17.30M | — | — | — |